Proto Labs (NYSE:PRLB) reported Q2 EPS of $0.46, $0.07 better than the analyst estimate of $0.39. Revenue for the quarter came in at $126.9 million versus the consensus estimate of $127.92 million.
Proto Labs (NYSE:PRLB) reported Q2 EPS of $0.46, $0.07 better than the analyst estimate of $0.39. Revenue for the quarter came in at $126.9 million versus the consensus estimate of $127.92 million.